Evidence map›Paper›PMID 34145318›Full record

ArticleScientific reports2021

Identifying HLA DRB1-DQB1 alleles associated with Chlamydia trachomatis infection and in silico prediction of potentially-related peptides.

Leidy Pedraza, Milena Camargo, Darwin A Moreno-Pérez, Ricardo Sánchez, Luisa Del Río-Ospina, Indira M Báez-Murcia, Manuel E Patarroyo, Manuel A Patarroyo

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Medicina (Kaunas, Lithuania) · 2024
    Article
  2. Review
  3. International journal of molecular sciences · 2023
    Article
  4. Medicine and pharmacy reports · 2023
    Review
  5. Genetic susceptibility loci forFrontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Leidy Pedraza *Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), 111321, Bogotá D.C., Colombia.
Milena Camargo *Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), 111321, Bogotá D.C., Colombia.
Darwin A Moreno-Pérez *Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), 111321, Bogotá D.C., Colombia.
Ricardo SánchezMolecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), 111321, Bogotá D.C., Colombia.
Luisa Del Río-OspinaMolecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), 111321, Bogotá D.C., Colombia.
Indira M Báez-MurciaMolecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), 111321, Bogotá D.C., Colombia.
Manuel E PatarroyoMolecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), 111321, Bogotá D.C., Colombia.
Manuel A PatarroyoMolecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), 111321, Bogotá D.C., Colombia. mapatarr.fidic@gmail.com.
Fundación Instituto de Inmunología de Colombia · COUniversidad Nacional de Colombia · COUniversity of Applied and Environmental Sciences · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HLA class II (HLA-II) genes' polymorphism influences the immune response to Chlamydia trachomatis (Ct), it is considered a sexually transmitted infection. However, associations between HLA-II alleles and Ct-infection have been little explored in humans; this study was thus aimed at determining HLA-DRB1-DQB1 alleles/haplotypes' effect on Ct-infection outcome in a cohort of Colombian women. Cervical sample DNA was used as template for detecting Ct by PCR and typing HLA-DRB1-DQB1 alleles/haplotypes by Illumina MiSeq sequencing. Survival models were adjusted for identifying the alleles/haplotypes' effect on Ct-outcome; bioinformatics tools were used for predicting secreted bacterial protein T- and B-cell epitopes. Sixteen HLA-DRB1 alleles having a significant effect on Ct-outcome were identified in the 262 women analysed. DRB1*08:02:01G and DRB1*12:01:01G were related to infection-promoting events. Only the DQB1*05:03:01G allele related to clearance/persistence events was found for HLA-DQB1. HLA-DRB1 allele homozygous women were associated with events having a lower probability of clearance and/or early occurrence of persistence. Twenty-seven peptides predicted in silico were associated with protective immunity against Ct; outer membrane and polymorphic membrane protein-derived peptides had regions having dual potential for being T- or B-cell epitopes. This article describes HLA-DRB1-DQB1 alleles/haplotypes related to Ct-infection resolution and the peptides predicted in silico which might probably be involved in host immune response. The data provides base information for developing future studies leading to the development of effective prevention measures against Ct-infection.

Indexed as

AllelesChlamydia trachomatisGenetic Predisposition to DiseaseAdultAmino Acid SequenceChlamydia InfectionsEpitope MappingEpitopesFemaleGene FrequencyHaplotypesHLA-DQ beta-ChainsHLA-DRB1 ChainsHumansKaplan-Meier EstimateMaleEpitopesHLA-DQB1 antigenHLA-DQ beta-ChainsHLA-DRB1 ChainsPeptides

Identifiers

PMID34145318
PMCPMC8213839
OpenAlexW3170630049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.